Position in BIIB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,045,472
-$129,381,612 QoQ
Shares Held
88,149
-89.1% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#124
of 1,036 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Derivatives in BIIB
reported options exposure · as of Jun 30, 2026CallValue
$64,818
CallShares
300
PutValue
$64,818
PutShares
300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $681,590,231 across 11 Drug Manufacturers - General names. BIIB ranks #7 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
1,437,685 | $181,637,122 | |
| 2 | GSK |
GSK plc
|
2,652,881 | $139,064,022 | |
| 3 | AZN |
Astrazeneca PLC
|
711,547 | $134,923,542 | |
| 4 | ABBV |
AbbVie Inc.
|
366,836 | $92,310,611 | |
| 5 | MRK |
Merck & Co., Inc.
|
380,081 | $48,840,408 | |
| 6 | SNY |
Sanofi
|
820,078 | $34,984,527 | |
| 7 | BIIB |
Biogen Inc.
This page
|
88,149 | $19,045,472 | |
| 8 | NVS |
Novartis AG
|
106,157 | $16,636,925 |
All Filings in BIIB
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,818 | 300 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $19,045,472 | 88,149 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $64,818 | 300 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $861,651 | 4,700 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $148,427,084 | 809,617 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $495,093,660 | 2,813,192 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $176,253,985 | 1,001,500 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $140,080,000 | 1,000,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $542,515,972 | 3,872,901 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $481,226,593 | 3,831,727 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $31,397,500 | 250,000 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $55,729,047 | 407,257 | Shares | Defined | 2025-07-21 | |
| 2023-09-30 | $12,362,181 | 48,100 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $178,213,838 | 625,641 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $193,262,267 | 695,113 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $339,538,258 | 1,226,124 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $448,021,194 | 1,677,982 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $92,955,852 | 455,800 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $20,175,480 | 95,800 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,399,200 | 10,000 | Call | Defined | 2022-02-14 | |
| 2021-12-31 | $146,711,080 | 611,500 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $8,730,807 | 30,852 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $85,011,362 | 245,506 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $32,283,150 | 115,400 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $48,668,373 | 198,760 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $32,890,710 | 115,943 | Shares | Defined | 2020-11-16 | |
| 2020-03-31 | $22,020,048 | 69,600 | Call | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||